BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38279594)

  • 1. Health-related quality of life and its influencing factors in patients with primary cutaneous B-cell lymphomas: A multicentric study in 100 patients.
    Schirren AEC; Albrecht JD; Melchers S; Weiß C; Büttner S; Dippel E; Gosmann J; Jonak C; Klemke CD; Laturnus-Chang M; Livingstone E; Mitteldorf C; Schummer P; Stadler R; Stranzenbach R; Weyer-Fahlbusch SS; Wobser M; Ziemer M; Nicolay JP
    J Eur Acad Dermatol Venereol; 2024 May; 38(5):954-966. PubMed ID: 38279594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of life and psychological distress in patients with cutaneous lymphoma.
    Sampogna F; Frontani M; Baliva G; Lombardo GA; Alvetreti G; Di Pietro C; Tabolli S; Russo G; Abeni D
    Br J Dermatol; 2009 Apr; 160(4):815-22. PubMed ID: 19120325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients' Illness Perception as a Tool to Improve Individual Disease Management in Primary Cutaneous Lymphomas.
    Porkert S; Lehner-Baumgartner E; Valencak J; Knobler R; Riedl E; Jonak C
    Acta Derm Venereol; 2018 Feb; 98(2):240-245. PubMed ID: 29048099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics associated with significantly worse quality of life in mycosis fungoides/Sézary syndrome from the Prospective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study.
    Molloy K; Jonak C; Woei-A-Jin FJSH; Guenova E; Busschots AM; Bervoets A; Hauben E; Knobler R; Porkert S; Fassnacht C; Cowan R; Papadavid E; Beylot-Barry M; Berti E; Alberti Violetti S; Estrach T; Matin R; Akilov O; Vakeva L; Prince M; Bates A; Bayne M; Wachsmuch R; Wehkamp U; Marschalko M; Servitje O; Turner D; Weatherhead S; Wobser M; Sanches JA; McKay P; Klemke D; Peng C; Howles A; Yoo J; Evison F; Scarisbrick J
    Br J Dermatol; 2020 Mar; 182(3):770-779. PubMed ID: 31049926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health-related Quality of Life in Cutaneous Lymphomas: Past, Present and Future.
    Jonak C; Porkert S; Oerlemans S; Papadavid E; Molloy K; Lehner-Baumgartner E; Cozzio A; Efficace F; Scarisbrick J
    Acta Derm Venereol; 2019 Jun; 99(7):640-646. PubMed ID: 30868169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health-related quality-of-life assessment in patients with cutaneous T-cell lymphoma.
    Demierre MF; Tien A; Miller D
    Arch Dermatol; 2005 Mar; 141(3):325-30. PubMed ID: 15781673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Primary cutaneous B-cell lymphomas: study of 22 cases].
    Martín Carrasco P; Morillo Andújar M; Pérez Ruiz C; de Zulueta Dorado T; Cabrera Pérez R; Conejo-Mir J
    Med Clin (Barc); 2016 Sep; 147(5):207-210. PubMed ID: 27427313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reclassification of 300 primary cutaneous B-Cell lymphomas according to the new WHO-EORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers.
    Senff NJ; Hoefnagel JJ; Jansen PM; Vermeer MH; van Baarlen J; Blokx WA; Canninga-van Dijk MR; Geerts ML; Hebeda KM; Kluin PM; Lam KH; Meijer CJ; Willemze R
    J Clin Oncol; 2007 Apr; 25(12):1581-7. PubMed ID: 17353548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skindex-29 scores indicate poor quality of life in early stage mycosis fungoides.
    Shalabi D; Kartan S; O'Donnell M; Zaya R; Zhan T; Shi W; Alpdogan O; Porcu P; Nikbakht N
    J Dermatol Sci; 2020 May; 98(2):98-101. PubMed ID: 32362434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The applicability and prognostic value of the new TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome: results on a large cohort of primary cutaneous B-cell lymphomas and comparison with the system used by the Dutch Cutaneous Lymphoma Group.
    Senff NJ; Willemze R
    Br J Dermatol; 2007 Dec; 157(6):1205-11. PubMed ID: 17941944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dermal infiltrates of cutaneous T-cell lymphomas with epidermotropism but not other cutaneous lymphomas are abundant with langerin⁺ dendritic cells.
    Der-Petrossian M; Valencak J; Jonak C; Klosner G; Dani T; Müllauer L; Pehamberger H; Knobler R; Trautinger F
    J Eur Acad Dermatol Venereol; 2011 Aug; 25(8):922-7. PubMed ID: 21054571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multidrug resistance related proteins in primary cutaneous lymphomas.
    van Haselen CW; Flens MJ; Scheper RJ; van der Valk P; Scheffer GL; Toonstra J; van Vloten WA
    Adv Exp Med Biol; 1999; 457():119-31. PubMed ID: 10500787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatostatin receptor scintigraphy in primary cutaneous T- and B-cell lymphomas.
    Valencak J; Trautinger F; Raderer M; Chott A; Der-Petrossian M; Ivancic-Brandenberger E; Knobler R; Kurtaran A; Hoffmann M
    J Eur Acad Dermatol Venereol; 2010 Jan; 24(1):13-7. PubMed ID: 19515078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency of primary cutaneous lymphoma variants in Austria: retrospective data from a dermatology referral centre between 2006 and 2013.
    Eder J; Kern A; Moser J; Kitzwögerer M; Sedivy R; Trautinger F
    J Eur Acad Dermatol Venereol; 2015 Aug; 29(8):1517-23. PubMed ID: 25600184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary cutaneous B-cell lymphomas.
    Kempf W; Denisjuk N; Kerl K; Cozzio A; Sander C
    J Dtsch Dermatol Ges; 2012 Jan; 10(1):12-22; quiz 23. PubMed ID: 22212142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary cutaneous lymphoma in southern Brazil: a 12-year single-center experience.
    Nudelmann LM; Bonamigo RR
    Int J Dermatol; 2015 Dec; 54(12):e512-20. PubMed ID: 26496535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of Epstein-Barr virus and human herpesvirus 7 and 8 genomes in primary cutaneous T- and B-cell lymphomas.
    Nagore E; Ledesma E; Collado C; Oliver V; Pérez-Pérez A; Aliaga A
    Br J Dermatol; 2000 Aug; 143(2):320-3. PubMed ID: 10951139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intralesional and intravenous treatment of cutaneous B-cell lymphomas with the monoclonal anti-CD20 antibody rituximab: report and follow-up of eight cases.
    Kerl K; Prins C; Saurat JH; French LE
    Br J Dermatol; 2006 Dec; 155(6):1197-200. PubMed ID: 17107389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary cutaneous B-cell lymphoma: a clinical, histological, phenotypic and genotypic study of 21 cases.
    Grønbaek K; Møller PH; Nedergaard T; Thomsen K; Baadsgaard O; Hou-Jensen K; Zeuthen J; Guldberg P; Ralfkiaer E
    Br J Dermatol; 2000 May; 142(5):913-23. PubMed ID: 10809848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and ten-year follow-up of primary cutaneous lymphomas: a single-centre cohort study.
    Maurelli M; Tessari G; Colato C; Schena D; Girolomoni G
    Eur J Dermatol; 2018 Feb; 28(1):44-49. PubMed ID: 29171395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.